Kom Op Tegen Kanker

• NCT05872204

  Collaborator, Phase 2, Recruiting, 100 people, 24 May 2023

• NCT04724928

  Collaborator, Phase 2, Recruiting, 156 people, 26 Jan 2021

• NCT04512638

  Collaborator, Phase 4, Status unknown, 125 people, 13 Aug 2020

• NCT04257461

  Collaborator, Phase 3, Status unknown, 30 people, 6 Feb 2020

• NCT03926936

  Collaborator, Phase 2, Completed, 17 people, 25 Apr 2019

• NCT03903835

  Collaborator, Phase 3, Recruiting, 750 people, 4 Apr 2019

• NCT03464305

  Collaborator, Phase 3, Active, not recruiting, 148 people, 14 Mar 2018

• NCT03192059

  Collaborator, Phase 2, Completed, 43 people, 19 Jun 2017

• Engineered adipose-derived stem cells with self-amplifying RNA enhance vascular network formation in porous GelMA hydrogels

  15 Sept 2026

• An unfavorable biologic profile associated with decreased overall survival and cancer-specific survival in non-metastatic breast cancer: A latent class analysis

  13 Feb 2026

Sources: api.crossref.org